Browse by Industry
Filter News
Found 24,510 articles
-
Middle East and Africa pharma economy to reach US$38.8bn by 2021
8/15/2018
CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region.
-
And now, this
6/20/2018
There are no words to describe and acknowledge this historic moment in Canada.
-
LUNGevity Foundation Kicks Off New Marketing Campaign to Raise Awareness of the Impact of Lung Cancer
6/13/2018
"234" asks the public to help change lung cancer statistics
-
Nicole Fevrier Davis Opens New MindBody Mastery Studio and Adds Psychic Assessments and Neurofeedback to her List of Unique Fitness Training Services
5/1/2018
Psychic personal trainer Nicole Fevrier Davis is slated to open her new studio at 10 Roberts Lane in Ridgefield CT on May 2nd.
-
The industry group PhRMA released its 2018 PhRMA member annual survey along with the 2018 Biopharmaceutical Research Industry Profile. Among the findings was that overall research-and-development spending was at an all-time high in 2017, hitting $71.4 billion, up from $65.5 billion in 2016 and fr...
-
Janssen Pharmaceutical Companies from Johnson & Johnson, confirmed topline data from its Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS) trial of its two-drug combination for HIV.
-
Generally speaking, the larger the animal, the more cells they have, the more likely they are to get cancer. The longer an animal lives, even if that animal is a human being, the higher the likelihood of cancer. Except elephants. Elephants rarely get cancer.
-
RXi Pharmaceuticals, headquartered in Marlborough, Mass., signed a research collaboration deal with Sweden’s Karolinska Institute. They will work to develop cancer therapies using RXi’s sd-rxRNA compounds against targets involved in T-cell and NK cell differentiation.
-
Foster City, Calif.-based Gilead Sciences reorganized some of its executive leadership team after it was announced that Chief Medical Officer Andrew Cheng is leaving the company to pursue other opportunities.
-
It’s not easy to predict trends in drugs, especially with breakthroughs in immunology and genetic engineering often causing dramatic changes in how biopharma companies approach new drugs.
-
Express Scripts is already known for its role of bringing prescriptions to the doors of consumers. Now the company is moving into a new area of providing medicines—expensive gene therapies.
-
Days after it closed on a $42 million Series A funding round, Karuna Pharmaceuticals has named a new chief executive officer. The company appointed industry veteran and founder of Sage Therapeutics Steven Paul as its new top officer.
-
Here's Five Vaccines to Keep Your Eye on
8/15/2018
On a dollar-for-dollar basis, vaccines have probably had a greater positive effect on global health than any other medical advancement, except possibly antibiotics. Yet as a whole, it’s an area that pharma companies tend to not spend a lot of resources on. But there are still many companies that ... -
ProQR to Present Interim Phase 1/2 Results for QR-110 in Leber’s Congenital Amaurosis 10 at the Symposium for Retinal Degeneration on Sept. 5th
8/15/2018
Presentation at the 18th International Symposium on Retinal Degeneration (RD2018) at 8:30 am GMT on Sept. 5th
-
VisualDx to Launch AI-Enabled Smart Symptom Checker
8/15/2018
VisualDx, the leading diagnostic clinical decision support tool for physicians, has announced the beginning of a beta test for its new artificial intelligence-driven symptom checker app, Aysa.
-
Branded Direct-to-Consumer Advertising Likely to Provide a Bump in Patient Requests for Sanofi/Regeneron's Dupixent, but Insurance Coverage and Out-of-Pocket Costs Continue to be Key Barriers for the Only Approved Atopic Dermatitis Biologic
8/15/2018
According to the latest update from Spherix Global Insights, while dermatologists continue to report high satisfaction with the first FDA approved biologic, there is still a large unmet need for new pharmacologic treatments for atopic dermatitis.
-
Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy
8/15/2018
SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases.
-
Natera and Fox Chase Cancer Center to Collaborate on Kidney Cancer Study
8/15/2018
Natera, Inc. has partnered with Fox Chase Cancer Center to assess the company's Signatera™ customized circulating tumor DNA assay for recurrence monitoring of kidney cancer.
-
Adventist University of Health Sciences to Rebrand as AdventHealth University
8/15/2018
The full transition is expected to be completed by March 2019.
-
International Isotopes Inc. Announces Financial Results For The Second Quarter 2018
8/15/2018
The Company Reports A 43% Increase In Revenue And A 79% Reduction In Net Loss For The Six-Month Period Compared To 2017.